NASDAQ · INO
Inovio Pharmaceuticals, Inc.
$0.77-$0.16 (-16.89%)
Inovio Pharmaceuticals, Inc.’s quoted price sits in the lower half of its reported 52-week range, 71.63% below the high.
Loading market information…
XETRA · IS8.DE · EUR
Stock price, dividends, earnings
Quote as of Oct 4, 2023, 03:36 PM UTC. Cached market data; not a live quote.
One-year closing-price history · EUR. Historical prices are not a forecast.
ifa systems AG’s quoted price sits in the lower half of its reported 52-week range, 44.54% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
ifa systems AG’s forward annual dividend is €0.15 per share, paid annual. The forward yield is 5.68% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow ifa systems AG’s reporting calendar.
THE COMPANY BEHIND THE TICKER
ifa systems AG is a global health IT company that develops, markets, and installs specialized software solutions and components for ophthalmologists and eye clinics. A core offering is its Electronic Medical Record (EMR) system, exclusively designed for ophthalmology, which enables thorough documentation and administration of examination results and treatments. This EMR can be seamlessly implemented in specialist practices, eye centers, and hospital ophthalmology departments. The company's product suite also includes a medical device interface system for aggregating and merging diverse ophthalmic data from various sources, and a clinical decision support system that analyzes patient data to provide insights on guidelines, treatment modalities, and risks. An integrated software connection platform facilitates the integration and interoperability of different software products, while its workflow management software streamlines treatment processes. Additionally, ifa systems offers web-based registry solutions specifically for cataract and refractive surgery treatments. Founded in 1987, the company is headquartered in Frechen, Germany, and operates as a subsidiary of Topcon Europe B.V.
Latest available per-share figures in EUR. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 12:19 PM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
$0.77-$0.16 (-16.89%)
Inovio Pharmaceuticals, Inc.’s quoted price sits in the lower half of its reported 52-week range, 71.63% below the high.
€0.09€0.00 (0.0%)
Clovis Oncology, Inc.’s quoted price sits in the lower half of its reported 52-week range, 96.97% below the high.
€0.25€0.00 (0.0%)
co.don AG’s quoted price sits in the lower half of its reported 52-week range, 89.57% below the high.
€0.02€0.00 (0.0%)
BZAM Ltd.’s quoted price sits in the lower half of its reported 52-week range, 88.28% below the high.
€0.12€0.00 (0.0%)
MagForce AG’s quoted price sits in the lower half of its reported 52-week range, 97.04% below the high.
€0.13-€0.05 (-27.64%)
Medigene AG’s quoted price sits in the lower half of its reported 52-week range, 96.79% below the high.
€0.87€0.00 (0.0%)
Epigenomics AG’s quoted price sits in the lower half of its reported 52-week range, 45.28% below the high.
€0.05€0.00 (0.0%)
Paion AG’s quoted price sits in the lower half of its reported 52-week range, 80.0% below the high.
